Investors Overview

Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in ...
More

Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$3.59
Change (%) Stock is Up 0.38 (11.84%)
Volume43,988
Data as of 02/27/15 3:59 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
02/24/15Bacterin to Present at the 27th Annual ROTH Conference
BELGRADE, Mont., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger, will present at the 27th Annual ROTH Conference to be held March 8th - 11th at The Ritz Carlton, Laguna Niguel, CA. Bacterin's presentation will take place Wednesday, March 11, 2015 at 12:30 PM PT. A live broadcast of the conference presentation will be available. To access the broadca... 
Printer Friendly Version
02/17/15Bacterin Announces 1000th Lot of OsteoSelect(R) DBM Putty
BELGRADE, Mont., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it has eclipsed an operational milestone processing over 1000 lots of OsteoSelect DBM Putty. Every lot of OsteoSelect processed by Bacterin since inception has demonstrated an osteoinductive response (the ability to induce new bone formation) in an animal model. Although there a... 
Printer Friendly Version
01/12/15Bacterin Announces Preliminary Fourth Quarter 2014 Revenue
Fourth Quarter Total Revenue in the Range of $8.9 Million to $9.1 Million, an Increase of Approximately 8-10% Over the Same Period Last Year BELGRADE, Mont., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary unaudited revenue for the fourth quarter of 2014. The Company is expecting total revenue for the fourth quarter of 2... 
Printer Friendly Version
11/26/14Bacterin to Present at the 7th Annual LD Micro Conference
BELGRADE, Mont., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the LD Micro Conference 7th Annual Main Event, to be held December 4, 2014 at the Luxe Hotel in Los Angeles, CA. Bacterin's presentation will take place Thursday, December 4, 2014 at 1:30pm PT. Institutional investors that wish to re... 
Printer Friendly Version
More

Upcoming Events
DateTitle
03/11/15 12:30 p.m. PT
Bacterin International Holdings Inc at ROTH Capital 27th Annual Conference
LocationThe Ritz CarltonLaguna Niguel, CA
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.